IOSP
INNOSPEC INC.
Key Financials
Gross Profit
$492.4M
↓ 9.3%
Operating Income
$129.5M
↓ 27.2%
Revenue
$1.8B
↓ 3.7%
Net Income
$119.5M
↑ 42.1%
Total Assets
$1.8B
↑ 5.6%
EPS (Diluted)
$4.67
↑ 228.9%
Total Liabilities
$499.5M
↓ 3.7%
Shareholders' Equity
$1.3B
↑ 9.5%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 5/13/2026 | View on SEC |
| 10-Q | 5/8/2026 | View on SEC |
| 8-K | 5/8/2026 | View on SEC |
| SCHEDULE 13G | 4/30/2026 | View on SEC |
| SCHEDULE 13G | 4/29/2026 | View on SEC |
| SCHEDULE 13G/A | 3/27/2026 | View on SEC |
| DEFA14A | 3/26/2026 | View on SEC |
| DEF 14A | 3/26/2026 | View on SEC |
| ARS | 3/24/2026 | View on SEC |
| 4/A | 3/6/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | IOSP |
| Company Name | INNOSPEC INC. |
| CIK | 1054905 |
| Sector | Chemicals & Allied Products |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2800 |
| SIC Description | Chemicals & Allied Products |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 7203556451 |